NASDAQ: INTS - Intensity Therapeutics, Inc.

Yield per half year: -59.55%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Intensity Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2023-06-30
ISIN US45828J1034
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://intensitytherapeutics.com
Цена ао 5.33
Change price per day: +3.68% (1.9)
Change price per week: +4.79% (1.88)
Change price per month: -29.33% (2.7875)
Change price per 3 month: -48.56% (3.83)
Change price per half year: -59.55% (4.87)
Change price per year: -77.01% (8.57)
Change price per 3 year: 0% (1.97)
Change price per 5 year: 0% (1.97)
Change price per 10 year: 0% (1.97)
Change price per year to date: -35.41% (3.05)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 4.17 4
P/E 0 0
EV/EBITDA -5.69 0
Total: 2.75

Efficiency

Title Value Grade
ROA, % -60.93 0
ROE, % -80.06 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0193 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 76.95 8
Yield EPS, % 311.52 10
Total: 7.2
More

Institutions Volume Share, %
HOHIMER WEALTH MANAGEMENT, LLC 186464 1.36
Sigma Planning Corp 48144 0.35
Millennium Management LLC 24822 0.18
Geode Capital Management, LLC 23070 0.17
Blackrock Inc. 10239 0.07
Wells Fargo & Company 2480 0.02
Osaic Holdings Inc 2000 0.01
Tower Research Capital LLC (TRC) 1027 0.01
Glassman Wealth Services 200 0
JP Morgan Chase & Company 1 0

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.00866 17.09 1.54048



Head Job title Payment Year of birth
Mr. Lewis H. Bender M.A., M.B.A., M.S. Founder, President, CEO & Chairman of the Board 1.1M 1959 (66 years)
Mr. John Wesolowski CPA, M.B.A. Principal Accounting Officer & Controller 272.37k 1960 (65 years)
Mr. James M. Ahlers Executive Vice President of Corporate Finance 75.09k 1964 (61 year)
Mr. Brian Schwartz M.D. Executive Vice President of Clinical Development N/A
Mr. Joseph Talamo CPA, M.B.A. Chief Financial Officer N/A 1969 (56 years)

Address: United States, Westport. CT, 61 Wilton Road - open in Google maps, open in Yandex maps
Website: https://intensitytherapeutics.com